Palbotiz (Palbociclib) 100 mg
Palbotiz 100 (Palbociclib 100 mg) is a CDK4/6 inhibitor for breast cancer treatment.
Manufacturer: Tizig Pharma. A generic equivalent of Ibrance.
The "Dose Modification" Role:
The 100 mg strength is primarily used for dose management. If a patient experiences significant side effects (like severe neutropenia) on the standard 125 mg dose, doctors prescribe this 100 mg dose. It allows the patient to stay on this life-extending therapy with a safer toxicity profile while maintaining efficacy.
✅ Key Benefit: Offers a manageable alternative for patients sensitive to the maximum dose.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 04.03.2026
What Customers Say
No reviews yet
Your review can be the first!